TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: glucose concentration at the subcutaneous insulin delivery site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Interrectal distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User intentions to follow automated suggestions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive Function as Measured by Omissions on the CPT
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Withdrawal occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viability of human inflammatory skin graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Evaluation of inflammation around human inflammatory skin graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Severe (Grade 3-4) Acute Graft-Versus-Host Disease
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Palmar-plantar Erythrodysesthesia (PPE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in HDRS-21 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in N-PASS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver demand appraisals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Caregiver perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Caregiver negative Coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive sequelae at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vadadustat AUClast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vadadustat AUCinf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vadadustat Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: local and regional control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Well Being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AUC0-72 of Donepezil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non invasive blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Study Participants Experiencing Treatment-Related Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Enrolled Patients for Whom LEAD RT Dose Can be Successfully Administered Following MRI-guided Planning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to Complete Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: FACIT-F Subscale Score Change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Rise in Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Automatic Thoughts Questionnaire (ATQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ways of Coping Questionnaire (WCQ)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Incidence of hospital-acquired ESBL-EC colonization or infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Haemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic performance of AI-assisted polyp detector
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Were Alive at 1 Year Post Transplant
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Who Were Alive at 2 Years Post Transplant
Endpoint domain: Mortality/survival
Primary endpoint: New fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: wound complication type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: need for secondary operation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: degree of agreement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cardiopulmonary events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in KSS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in SF-36 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in WOMAC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Healing time of second degree burns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of POCD 7 days after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of postoperative delirium after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxygen desaturations associated with sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change in total incontinence episode frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sum of the Pain Intensity Differences (SPID) Over 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration of CG200745 (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve (AUC 0-72h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Discontinue Study Treatment Due to Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Limbal Redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: Bulbar Redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: Tarsal Roughness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: Number of Acute Infusion Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Echocardiography time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of increase of fractional expired oxygen level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: local protein turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole body protein turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of cardiac arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse event rate (CTCAE v. 3.0)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of pressure ulcers Cat. II-IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage difference in expired tidal volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of postpartum depression
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of complete remissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and severity of local injection site reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of systemic reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of adverse events (AEs) categorized by MedDRA System Organ Class
Endpoint domain: Adverse events/effects
Primary endpoint: Report of the number of participants with early discontinuation of vaccinations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Test 1 scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of extravasated leukocytes in skin blisters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change of sitting diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline to Week 4 in Meibomian Gland Score (MGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline to Week 4 in Tear Break-Up Time (TBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence (Number) of Device- or Procedure-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Overt Aggression Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Score Difficulties in Emotion Regulation Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotion Regulation Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Screw integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Unified Parkinson's Disease Rating Scale for evaluating motor subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hoehn and Yahr scale for assessing clinical stage of PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDQ-39 for assessing quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Endorsed and Anticipated Stigma Inventory (EASI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PTSD Checklist (PCL-V)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PTSD Treatment Initiators
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Amount of biofilm formed on the denture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative measure of color vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking speed of participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-viral immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Variation of VO2 peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days until no positional vertigo could be induced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related serious adverse event rate (TRSAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Successful engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: presence of atherogen dyslipidemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: presence of increased non-HDL cholesterol level of the sera
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in % of confirmed positive diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct placement of feeding tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in self reported physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Volume of postoperative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alteration in magnitude of neo-antigen specific T cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety as measured by SUSARs
Endpoint domain: Adverse events/effects
Primary endpoint: Alteration in breadth of neo-antigen specific T cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Association with acute myeloid leukemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 30-Day Readmission Rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Detection of congenital abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Postterm pregnancy inductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Improved cardiopulmonary exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical horizontal width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of positive Propionibacterium acnes sample after therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Beverage hydration index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and disability of the shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of relapse cases
Endpoint domain: Mortality/survival
Primary endpoint: Change in mobility limitations
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in self-perception of mobility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: children's physical growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's development (mental, motor, social and emotional)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: N-back Task - Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-back Task - Error Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AX Continuous Performance Test Task D-prime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparing to Overcome Prepotency (POP) Task - Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparing to Overcome Prepotency Task - Error Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in stigma scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Any employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Weighted Modified Rankin Scale (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unit volumes of blood obtained from serum donors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Total MRI Functional Tumor Volume Change From Baseline to Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Total MRI Functional Tumor Volume Change From Baseline to Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical improvement documented with KOOS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cannabinoids levels change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in attention span
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in cognitive level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bladder catheterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: proportions of participants with good or excellent bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: proportions of participants with poor/inadequate bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total Number of Cases With at Least One Provider Response
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: histological effects of cryospray therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMSA uptakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain secondary to breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization of health workers
Endpoint domain: Mortality/survival
Primary endpoint: Positive predictive value of screening protocols
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous Compliance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Correct Compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically Significant Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: safety of carboplatin administration
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Cardiac Conduction Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Changes in Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Viral Infections of Interest
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Dermatologic Alterations - Basal Cell Carcinoma
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time 0 to 72 hours (AUC [0-72h])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time 0 to 168 hours (AUC[0-168h])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Westley croup score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 or 4 Adverse Events Attributed to the Vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Significant Decrease in CD4+ Cell Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Significant Increase in HIV Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of acute toxicity (CTCAE grade 2 or higher)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Serious (unexpected) Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Geometrical accuracy of targeting by online MR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CAD findings by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CMD findings by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of acute myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction With Genomic Test Report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSSI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intensity of hot flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Perception of Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Perception of Discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Perception of Swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Levels of Difficulties in Mastication
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Analgesic Consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Control of Asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saliva Production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from 0 to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Reporting at Least 1 TEAE Related to Laboratory Assessments
Endpoint domain: Adverse events/effects
Primary endpoint: Normalization of GSIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Body movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in the Autism Behavior Inventory (ABI) Core Domain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in ABI Social Communication Domain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in ABI Repetitive/Restrictive Behavior (RRB) Domain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (Confirmed and Unconfirmed, Complete and Partial Responses)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first rescue analgesia after TAP block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes